Top Tweets for #WelcometoBiocom

1 day ago

It's time to welcome our new members! #WelcometoBiocom, #CatalYm develops immunotherapies for solid tumors, targeting and neutralizing GDF-15 to reverse cancer therapy resistance and enhance anti-PD-1 efficacy. #DigitalBiotechnologies is engineering the first solid-state next-generation sequencing platform designed specifically for clinical medicine. @enzenebio provides end-to-end biologics development, manufacturing and supply services. Inapill develops first-in-class, orally available small molecule therapeutics targeting immunometabolism to treat inflammatory, autoimmune and age-related diseases. #MiteraBiosciences develops investigational therapeutics as alternatives to traditional immunosuppressive treatments for autoimmune and alloimmune disorders. #PrimaryBioscience is designing a single-molecule protein sequencing device for comprehensive, multibiomarker screening.

Biocom's tweet photo. It's time to welcome our new members! #WelcometoBiocom, #CatalYm develops immunotherapies for solid tumors, targeting and neutralizing GDF-15 to reverse cancer therapy resistance and enhance anti-PD-1 efficacy. #DigitalBiotechnologies is engineering the first solid-state next-generation sequencing platform designed specifically for clinical medicine. @enzenebio provides end-to-end biologics development, manufacturing and supply services. Inapill develops first-in-class, orally available small molecule therapeutics targeting immunometabolism to treat inflammatory, autoimmune and age-related diseases. #MiteraBiosciences develops investigational therapeutics as alternatives to traditional immunosuppressive treatments for autoimmune and alloimmune disorders. #PrimaryBioscience is designing a single-molecule protein sequencing device for comprehensive, multibiomarker screening.

Biocom @Biocom

3 days ago

It's time to welcome our new members! #WelcometoBiocom, #Antogen provides immunopeptidomics services to identify and quantify peptide–HLA ligands from biological samples, supporting discovery and translational research in oncology, immunotherapy development and autoimmune disease. #Invizix develops noninvasive bioelectronic therapies using a waveform discovery engine and bedside delivery device designed to treat chronic disease during sleep. #Pastør21 AI deploys high-throughput sequencing and explainable AI to deliver pathogen intelligence and track antimicrobial-resistant bacterial strains. #RosemanBioventures provides startups and emerging life science companies in Las Vegas with turnkey laboratories, research infrastructure, regulatory guidance and connections to investors and industry partners to accelerate commercialization. #Stormlight is developing a therapeutic platform designed to gain biological control over cancer’s adaptability and overcome therapy-resistant malignancies. @wieldtx develops treatments for autoimmune diseases by combining human genetic validation with genetic and multi-omic data to identify targets involved in the root causes of inflammation.

Biocom's tweet photo. It's time to welcome our new members! #WelcometoBiocom, #Antogen provides immunopeptidomics services to identify and quantify peptide–HLA ligands from biological samples, supporting discovery and translational research in oncology, immunotherapy development and autoimmune disease. #Invizix develops noninvasive bioelectronic therapies using a waveform discovery engine and bedside delivery device designed to treat chronic disease during sleep. #Pastør21 AI deploys high-throughput sequencing and explainable AI to deliver pathogen intelligence and track antimicrobial-resistant bacterial strains. #RosemanBioventures provides startups and emerging life science companies in Las Vegas with turnkey laboratories, research infrastructure, regulatory guidance and connections to investors and industry partners to accelerate commercialization. #Stormlight is developing a therapeutic platform designed to gain biological control over cancer’s adaptability and overcome therapy-resistant malignancies. @wieldtx develops treatments for autoimmune diseases by combining human genetic validation with genetic and multi-omic data to identify targets involved in the root causes of inflammation.

111

Top Tweets for #WelcometoBiocom

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users